-
Prasco
Distance: 1.4 Mi7155 E Kemper Rd
45249 Cincinnati -
Camargo Pharmaceutical Services, LLC.
Distance: 1.8 Mi9825 Kenwood Rd. Ste. 102
45242 Cincinnati -
Glaser Research Group
Distance: 8.0 Mi815 Floral Ave
45174-1213 Terrace Park -
Ausio Pharmaceuticals, LLC
Distance: 9.3 Mi1776 Mentor Ave
45212-3554 Cincinnati -
Nnodum-ziks
Distance: 9.7 Mi886 Clinton Springs Ave
45229-1404 Cincinnati
Description
With more than 20 years of experience in this discipline, Triplefin has created innovative sampling solutions that are custom-tailored to meet the needs of your brand. Through the use of vouchers, co-pay assistance cards, loyalty cards, mail-in rebates or web/text coupons, Triplefin has the right solution for your alternative sampling needs.
Triplefin , founded in 1981, is privately owned and headquartered in Cincinnati, Ohio. Triplefin provides strategic, customized brand support and growth solutions to leading pharmaceutical manufacturing companies. Our mission is to connect patients, providers, pharmacies, and payers to improve outcomes and to remove brand challenges with access, acquisition, and adherence.
Mr. Doyle served first as director and most recently, as vice president of new business development for Smith Medical Partners, a wholly owned subsidiary of H.D. Smith. He has more than 25 years of experience in the pharmaceutical industry, in both brand and distribution companies. Mr. Doyle’s roles have ranged from directing trade and U.S. commercial operations, leading 3M’s Canadian pharmaceutical business unit to business development, and strategic planning.
We provide you the ability to exercise certain controls and choices regarding our collection, use and sharing of your information.
Triplefin is recognized as the premier provider of pharmaceutical marketing support solutions. For more than 30 years, Triplefin has continually helped pharmaceutical brand managers remove barriers to brand access and adherence and put prescription brands into patients’ hands…and keep them there throughout treatment. Today, more than 40 pharmaceutical manufacturing companies (including 14 of the top 20), representing more than 150 brands across multiple therapeutic categories, have connected with Triplefin and experienced success with Triplefin’s solutions.